Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.

The remarks suggest that Eli Lilly’s initial efforts to expand manufacturing capacity for Mounjaro are paying off as demand for the diabetes treatment soars.

Previous post Deal-hungry shoppers will squeeze holiday sales growth to pre-pandemic levels, retail group says
Next post Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month